We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, annonce que...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on addressing the factors driving the progression of neurodegenerative and autoimmune...
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...
Regulatory News: La société GENEURO (Paris:GNRO) et la société GILBERT DUPONT ont mis fin au contrat de liquidité conclu le 06 mars 2021. Cette résiliation a pris effet le 30 juin 2024 au soir. A...
Market: Euronext Paris ISIN code / Mnemo: CH0308403085 / GNRO Web site: www.geneuro.com Regulatory News: Pursuant to the liquidity contract entrusted by GENEURO SA (Paris:GNRO) to Gilbert Dupont...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0082 | -11.8155619597 | 0.0694 | 0.0728 | 0.0612 | 19146 | 0.06912828 | DE |
4 | -0.0138 | -18.4 | 0.075 | 0.0848 | 0.0612 | 15439 | 0.07478527 | DE |
12 | -0.0088 | -12.5714285714 | 0.07 | 0.1 | 0.0612 | 31283 | 0.0752731 | DE |
26 | -1.9688 | -96.9852216749 | 2.03 | 2.35 | 0.0558 | 61240 | 0.23457857 | DE |
52 | -1.0038 | -94.2535211268 | 1.065 | 2.35 | 0.0558 | 35030 | 0.35167203 | DE |
156 | -3.5788 | -98.3186813187 | 3.64 | 4.24 | 0.0558 | 15178 | 0.85258069 | DE |
260 | -3.4188 | -98.2413793103 | 3.48 | 6.28 | 0.0558 | 11990 | 1.5117658 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions